The global rare disease genetic testing market size is expected to reach USD 1.8 Billion by 2027 according to a new study by Polaris Market Research. The report “Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Neurological Disorders, Immunological Disorders, Hematology Ailments, Endocrine & Metabolism Disorders, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders, Dermatology Disorders, Others); By Technology; By Specialty; By End-Use; By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growing need for on-time diagnosis of uncommon disorders, rising prevalence of rare disorders, innovations in genomic testing, and the focused approach of the market player’s in cost-effective treatments are the key factors responsible for market growth. Moreover, government-sponsored schemes are also expected to positively impact the market. In February 2020, the government of India announced financial assistance of INR 15 lacs to the patients suffering from uncommon ailments under the Rashtriya Arogaya Nidhi scheme for a one-time treatment.
The global rare disease genetic testing industry is fragmented based on disease type, technology, specialty, end-use, and region. In terms of disease type, the market is segmented into neurological disorders, immunological disorders, hematology illnesses, endocrine & metabolism ailments, cancer, musculoskeletal disorders, cardiovascular disorders, dermatology illnesses, and others.
Based on technology, the rare disease genetic testing industry is further bifurcated into next-generation sequencing, array technology, PCR-based testing, FISH, sanger sequencing, and karyotyping. Based on specialty, the rare disease genetic testing industry is further bifurcated into molecular, chromosomal, and biochemical genomic tests. Based on end-use, the rare disease genomic testing industry is further bifurcated into research laboratories & CROs, hospitals & clinics, and diagnostic laboratories.
Request a sample this report by clicking the following link: https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing-market/request-for-sample
Segment Highlights
- Neurological ailments accounted for the largest revenue share in 2019 on account of the increasing prevalence of neurologic disorders across the globe and presence of numerous testing techniques
- Based on technology, the next generation sequencing segment is projected to constitute almost half of the market in 2027. The usage of the technology in whole genome sequencing is the key factor responsible for its segment’s growth.
- Molecular tests are expected to account for the highest revenue share by the end of 2027. The availability of advanced technologies and ability to test ultra-rare disorders is expected to drive market growth.
- Research laboratories & CROs accounted for the largest revenue share in 2019 owing to the increasing number of tests and growing occurrence of rare disorders across the developed economies
List of Key Players
- Strand Life Sciences
- Myriad Genetics
- Quest Diagnostics Inc.
- Centogene N.V.
- Invitae Corporation
- Baylor Genetics
- Ambry Genetics
- Macrogen, Inc.
- Opko Health, Inc.
- Color Genomics, Inc.
- Health Network Laboratories
- Preventiongenetics, Progenity, Inc.
- Fulgent Genetics Inc.
- Others
The global solar panels market size is anticipated to reach USD 90.23 billion by 2026 growing at a CAGR of 12.4% from 2018 to 2026 according to a new report published by Polaris Market Research.
The increase in the adoption of renewable energy sources, significant investments in environmental protection, coupled with government initiatives aimed at increasing the adoption of solar panels majorly drives the market growth.
Increasing demand for sustainable energy solutions and government efforts in the form of incentives and schemes boost the market growth.
Growing concerns regarding environmental pollution caused by use of fossil fuels and their limited availability further support the market growth.
New emerging markets, and declining costs of photovoltaic materials would provide growth opportunities in the market in the coming years.
The growing urbanization, and depleting traditional energy sources has accelerated the market growth in the region.
In addition, global Concrete Admixture market report makes out and analyses the emerging trends along with major driving factors, challenges and opportunities in the market for Data Bridge Market Research industry.Concrete Admixture market is anticipated to observe growth during the forecast period due to growing demand at the end user level.
This report not only works to compete but also to outshine the competition.
It divides the global market size value and market volume by manufacturers, type, application, and region.
The Concrete Admixture business report has a lot to offer which will lend a hand in making a decision regarding the market.Globalization is attaining the highest level day by day and hence global market research has become quite imperative which helps businesses with decision making.
The global market research report provides estimations about the key factors of the DBMR industry with the precise and perfect data that is useful for the business.
By performing top to bottom examination of the DBMR industry, the report gives evaluations about the income, return on investment (ROI) and developing business strategies.
Dietary factors are identified as having a significant impact on cancer risk, with different dietary elements increasing as well as reducing risk.
Diet and obesity can be associated with up to 30% to 35% of deaths from cancer, whereas physical inactivity appears to be associated with 7% cancer risk.About 85% of all cases of cancer are caused by diet and lifestyle.
Clinical outcomes are significantly improved by using Oncology Nutrition as an integrated and holistic approach to cancer.Overall market growth is driven largely by shifting focus from parenteral to enteral nutrition, increasing cancer incidence, increasing demand for nutritional requirements in the home care sector, increasing number of patients being treated for malnutrition, and increasing the quality of nutritional interventions in clinical research.Top Companies Profiled in the Report Include: Hormel Foods (US), Fresenius Kabi AG (Germany), Meiji Holdings (Japan), Nestle S.A. (Switzerland), Mead Johnson Nutrition Company (US), Abbott Laboratories (US), Danone (France), B. Braun Melsungen AG (Germany), Victus (US), Global Health Products (US) and others.Get a sample of the report @ URL https://www.reportsanddata.com/sample-enquiry-form/1374Market Overview: The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness.
In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities.
Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.Request a discount on the report @ URL https://www.reportsanddata.com/discount-enquiry-form/1374The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R activities, and government and corporate deals, among others through extensive primary and secondary research.
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa.
The market always keep on changing and also new competitor always keep on emerging in the business, it's better to have a competitor analysis and get to know the future strategy to handle it.
https://www.aranca.com/competitive-intelligence.php Competition analysis, competitive landscape
“Global “Satellite Manufacturing and Launch Market” gives in-depth analysis of the parent market with important changes in market dynamics, analyse segmentation details of the market as former, on-going, and projected market in terms of volume and value.
The growing utilization of commercial satellite platforms for dual purposes, which include military and civil, is also providing growth opportunities to the market in focus.
This will provide new opportunities to extend satellite services in urban and rural areas to cover existing white zones and ensure seamless connectivity plans for a variety of users, including emergency services.
Satellite Manufacturing and Launch market report highlights the economy, past and emerging trend of industry, and availability of basic resources.
furthermore, the market report explains development trend, analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out in the end, the report makes some important proposals for a new project of Satellite Manufacturing and Launch market before evaluating its possibility.
Get a Sample Copy of the Report at - https://www.absolutereports.com/enquiry/request-sample/14326715
The global Soy Lecithin Market is expected to reach USD 1.33 Billion by 2027, according to a new report by Reports and Data.
The growth of the market is attributed to growing end-use applications of soy lecithin.
Soy lecithin is used as an emulsifier in the food & beverage industry to prevent margarine and cooking sprays from splattering when they are used for frying purposes.
Chocolate bars, which possess cocoa butter, sugar milk, and fine solid cocoa deploy soy lecithin, assists in stabilizing emulsions, as well as blending fats.The competitive landscape and company profiles offered in the report examine the key players in the Soy Lecithin market.
The competitive analysis scrutinizes strategic initiatives adopted by key players and evaluates recent developments and market standing of the companies.
The company profiles include data of established players and new entrants and are examined by using analytical tools like SWOT Analysis.Get sample copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/2783Key Players:Key participants include Cargill Inc., Archer Daniels Midland Company, Du Pont, American Lecithin Company, Ruchi Soya Industries Inc., LASENOR EMUL, Lipoid GmbH, Bunge Limited, Ceresking Ecology & Technology Co. Ltd., and Lecico GmbH, among others.Further key findings from the report suggest:By grade, feed grade soy lecithin held a substantial market share in 2018, as it is considered suitable for consumption by animals and providing them sufficient nutrition for the health.Soy lecithin is used to support the blending of ingredients, which makes it a great wetting agent.
